About: http://webisa.webdatacommons.org/365429976

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	YM was a drug development company primarily focused on advancing momelotinib --- CYT387, an orally administered, once-daily candidate for hematologic cancers.
http://www.w3.org/ns/prov#wasQuotedFrom	fool.com